Showing results (231-240 of 256) with videos related to
Sort By:
Pageof 26
Nature Communications|July 15, 2024
Large-scale whole-exome sequencing analyses identified protein-coding variants associated with immune-mediated diseases in 350,770 adultsLiu Yang, Ya-Nan Ou, Bang-Sheng Wu, et al.Scientific Reports|November 4, 2017
Iron deposition in substantia nigra: abnormal iron metabolism, neuroinflammatory mechanism and clinical relevanceZhuo Liu, Hui-Cong Shen, Teng-Hong Lian, et al.Orthodontics & Craniofacial Research|December 3, 2024
CBCT Analysis of the Hyoid and Pharyngeal Airway Changes in Class III Patients With Orthognathic SurgerySi-Mai Chen, Hua-Yang Cai, Xing-Zhi Yan, et al.Cancer Letters|November 30, 2016
Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatmentHui-Lu Zhang, Ming-Da Wang, Xu Zhou, et al.Elife|May 19, 2020
MeCP2 in cholinergic interneurons of nucleus accumbens regulates fear learningYing Zhang, Yi Zhu, Shu-Xia Cao, et al.Plos One|October 3, 2015
Investigation on Abnormal Iron Metabolism and Related Inflammation in Parkinson Disease Patients with Probable RBDYang Hu, Shu-Yang Yu, Li-Jun Zuo, et al.Nature Human Behaviour|January 4, 2024
Exome sequencing identifies genes associated with sleep-related traitsChen-Jie Fei, Ze-Yu Li, Jing Ning, et al.Nature Medicine|January 16, 2019
Cannabinoid CB<sub>1</sub> receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behaviorChen-Jie Shen, Di Zheng, Ke-Xin Li, et al.Nature Medicine|February 1, 2019
Publisher Correction: Cannabinoid CB<sub>1</sub> receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behaviorChen-Jie Shen, Di Zheng, Ke-Xin Li, et al.BMC Psychiatry|August 2, 2022
Antepartum sleep quality, mental status, and postpartum depressive symptoms: a mediation analysisYu Wang, Han Liu, Chen Zhang, et al.Pageof 26